Pacific Edge (Pacific Edge) Debt-to-Equity : 0.08 (As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Pacific Edge Debt-to-Equity?

Pacific Edge's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.95 Mil. Pacific Edge's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.53 Mil. Pacific Edge's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $33.23 Mil. Pacific Edge's debt to equity for the quarter that ended in Mar. 2024 was 0.07.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Pacific Edge's Debt-to-Equity or its related term are showing as below:

PFGTF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.02 Max: 0.12
Current: 0.08

During the past 13 years, the highest Debt-to-Equity Ratio of Pacific Edge was 0.12. The lowest was 0.01. And the median was 0.02.

PFGTF's Debt-to-Equity is ranked better than
93.26% of 193 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.22 vs PFGTF: 0.08

Pacific Edge Debt-to-Equity Historical Data

The historical data trend for Pacific Edge's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Edge Debt-to-Equity Chart

Pacific Edge Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.11

0.12

0.02

0.08

Pacific Edge Semi-Annual Data
	Sep14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															0.02	0.02	0.02	0.02	0.08

Competitive Comparison of Pacific Edge's Debt-to-Equity

For the Diagnostics & Research subindustry, Pacific Edge's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pacific Edge's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pacific Edge's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Pacific Edge's Debt-to-Equity falls into.

Pacific Edge Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Pacific Edge's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.951	+	1.526)	/	33.225
	=	0.07

Pacific Edge's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.951	+	1.526)	/	33.225
	=	0.07

Pacific Edge (OTCPK:PFGTF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Pacific Edge Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Pacific Edge's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Pacific Edge (Pacific Edge) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Pacific Edge Ltd (OTCPK:PFGTF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

PEB:New Zealand PEB:Australia

Address

87 St David Street, P.O. Box 56, Dunedin, STL, NZL, 9016

Website

https://www.pacificedgedx.com

Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.